TY  - GEN
AU  - Ison,Gwynn
AU  - Beaver,Julia A
AU  - McGuinn,W David
AU  - Palmby,Todd R
AU  - Dinin,Jeannette
AU  - Charlab,Rosane
AU  - Marathe,Anshu
AU  - Jin,Runyan
AU  - Liu,Qi
AU  - Chen,Xiao Hong
AU  - Ysern,Xavier
AU  - Stephens,Olen
AU  - Bai,Ge
AU  - Wang,Yaning
AU  - Dorff,Sarah E
AU  - Cheng,Joyce
AU  - Tang,Shenghui
AU  - Sridhara,Rajeshwari
AU  - Pierce,William
AU  - McKee,Amy E
AU  - Ibrahim,Amna
AU  - Kim,Geoffrey
AU  - Pazdur,Richard
TI  - FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs
SN  - 1557-3265
PY  - 2018///0112
KW  - Acetates
KW  - chemistry
KW  - Animals
KW  - Antineoplastic Agents
KW  - Capecitabine
KW  - administration & dosage
KW  - Clinical Trials as Topic
KW  - Drug Approval
KW  - Drug Evaluation, Preclinical
KW  - Fluorouracil
KW  - Humans
KW  - Neoplasms
KW  - diagnosis
KW  - Prescription Drug Overuse
KW  - Research Design
KW  - Treatment Outcome
KW  - United States
KW  - United States Food and Drug Administration
KW  - Uridine
KW  - analogs & derivatives
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1158/1078-0432.CCR-16-0638
ER  -